{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:42:13Z","timestamp":1790779333618,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.virusres.2022.199030","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:21:05Z","timestamp":1672312865000},"page":"199030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cepharanthine inhibits dengue virus production and cytokine secretion"],"prefix":"10.1016","volume":"325","author":[{"given":"Patta","family":"Phumesin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutatip","family":"Panaampon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusho","family":"Kariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawornchai","family":"Limjindaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-thai","family":"Yenchitsomanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5206","authenticated-orcid":false,"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2022.199030_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: an update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.virusres.2022.199030_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005194","article-title":"Drivers of inter-individual variation in dengue viral load dynamics","volume":"12","author":"Ben-Shachar","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.virusres.2022.199030_bib0003","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2022.199030_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/274025","article-title":"Dengue virus infection causes the activation of distinct NF-kappaB pathways for inducible nitric oxide synthase and TNF-alpha expression in RAW264.7 cells","author":"Cheng","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.virusres.2022.199030_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/528805","article-title":"Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response","volume":"197","author":"Guilarde","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.199030_bib0006","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2022.199030_bib0007","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2022.199030_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4269\/ajtmh.2000.63.71","article-title":"Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production","volume":"63","author":"Huang","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virusres.2022.199030_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","article-title":"Validation of in-vitro bioassay methods: application in herbal drug research","volume":"46","author":"Indrayanto","year":"2021","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"10.1016\/j.virusres.2022.199030_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.virusres.2022.199030_bib0011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","article-title":"Drug repurposing of minocycline against dengue virus infection","volume":"478","author":"Leela","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2022.199030_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF02255946","article-title":"Immunopathogenesis of dengue virus infection","volume":"8","author":"Lei","year":"2001","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virusres.2022.199030_bib0013","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2022.199030_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.795756","article-title":"Cepharanthine suppresses herpes simplex virus type 1 replication through the downregulation of the PI3K\/Akt and p38 MAPK signaling pathways","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2022.199030_bib0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: an integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virusres.2022.199030_bib0016","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.bmcl.2014.03.041","article-title":"Cepharanthine inhibited HIV-1 cell-cell transmission and cell-free infection via modification of cell membrane fluidity","volume":"24","author":"Matsuda","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.virusres.2022.199030_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/164878","article-title":"Cells in dengue virus infection in vivo","author":"Noisakran","year":"2010","journal-title":"Adv. Virol."},{"key":"10.1016\/j.virusres.2022.199030_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102367","article-title":"Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment","volume":"24","author":"Ohashi","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.virusres.2022.199030_bib0019","unstructured":"Organization., W.H., 2011. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever., in: Regional Office for South-East Asia. Rev. and expanded. ed. New Delhi, I. (Ed.), p. 196."},{"key":"10.1016\/j.virusres.2022.199030_bib0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cbdd.12309","article-title":"Peptide inhibitors against dengue virus infection","volume":"84","author":"Panya","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.virusres.2022.199030_bib0021","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cbdd.12576","article-title":"A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection","volume":"86","author":"Panya","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.virusres.2022.199030_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00705-017-3666-9","article-title":"Vivo-morpholino oligomers strongly inhibit dengue virus replication and production","volume":"163","author":"Phumesin","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2022.199030_bib0023","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4161\/mabs.27874","article-title":"Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle","volume":"6","author":"Poungpair","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.virusres.2022.199030_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052215","article-title":"Cytokine expression profile of dengue patients at different phases of illness","volume":"7","author":"Rathakrishnan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2022.199030_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2015.10.005","article-title":"Inhibition of dengue virus production and cytokine\/chemokine expression by ribavirin and compound A","volume":"124","author":"Rattanaburee","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2022.199030_bib0026","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2022.199030_bib0027","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/lam.12186","article-title":"Human monoclonal single-chain antibodies specific to dengue virus envelope protein","volume":"58","author":"Saokaew","year":"2014","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.virusres.2022.199030_bib0028","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1349-7006.2010.01572.x","article-title":"Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB","volume":"101","author":"Seubwai","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.virusres.2022.199030_bib0029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2017.03.012","article-title":"Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties","volume":"246","author":"Smee","year":"2017","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2022.199030_bib0030","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1128\/JVI.02105-08","article-title":"Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production","volume":"84","author":"Subramanya","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2022.199030_bib0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0037-1612941","article-title":"The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome","volume":"87","author":"Suharti","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.virusres.2022.199030_bib0032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2013.05.094","article-title":"Compound A, a dissociated glucocorticoid receptor modulator, reduces dengue virus-induced cytokine secretion and dengue virus production","volume":"436","author":"Suttitheptumrong","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2022.199030_bib0033","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ijc.24521","article-title":"Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway","volume":"125","author":"Takahashi-Makise","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virusres.2022.199030_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001309","article-title":"Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue","volume":"5","author":"Tricou","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2022.199030_bib0035","article-title":"Dengvaxia: the world's first vaccine for prevention of secondary dengue","volume":"9","author":"Tully","year":"2021","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"10.1016\/j.virusres.2022.199030_bib0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.199030_bib0037","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/514048","article-title":"Dengue in the early febrile phase: viremia and antibody responses","volume":"176","author":"Vaughn","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.199030_bib0038","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jinf.2014.12.001","article-title":"Cellular microRNA-miR-548g-3p modulates the replication of dengue virus","volume":"70","author":"Wen","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.virusres.2022.199030_bib0039","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.virusres.2022.199030_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4149\/av_2014_01_20","article-title":"Growth characteristics and cytokine\/chemokine induction profiles of dengue viruses in various cell lines","volume":"58","author":"Yohan","year":"2014","journal-title":"Acta Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:18:39Z","timestamp":1759155519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170222003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"alternative-id":["S0168170222003598"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2022.199030","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cepharanthine inhibits dengue virus production and cytokine secretion","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2022.199030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199030"}}